NEW: The preliminary results of a major study of remdesivir show that hospitalized COVID-19 patients who received the drug recovered 31% faster. Dr. Anthony Fauci hailed the findings as 'quite good news.'
Preliminary results of a study of the antiviral drug remdesivir show it is effective in shortening recovery time for patients with COVID-19.Preliminary results of a study of the antiviral drug remdesivir show it is effective in shortening recovery time for patients with COVID-19.Preliminary results of a major study of the antiviral drug remdesivir show it can help hospitalized patients with COVID-19 recover faster. Dr.
Fauci said it was the first"truly high-powered" randomized placebo controlled trial of remdesivir, noting that it involved more than a thousand hospitalized patients at sites in numerous countries. Another randomized controlled trial in China, with results that were also announced Wednesday, was far smaller.
The preliminary results found that patients who received remdesivir recovered 31% faster — the median time to recovery was 11 days rather than 15 days. The results also suggest a slightly lower mortality rate for the group receiving remdesivir, but until complete data is analyzed it's not certain if that effect is significant.
And while the preliminary data showed no serious side effects of remdesivir,"we still don't have all the safety data reported from the NIH, and that will be critically important to understanding how we use this medicine in the future," he said."It is very important to understand that remdesivir and antivirals in general are not silver bullets," he said.They do not immediately get rid of an infection. They work by slowly preventing the virus from making more of itself.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Large coronavirus trial of drug remdesivir shows promiseRemdesivir appears to work the same in patients whether they receive five or 10 days of treatment.
Read more »
Large coronavirus trial of drug remdesivir shows promise, while another suggests no benefitRemdesivir appears to work the same in patients whether they receive five or 10 days of treatment. But another study suggested the drug has no benefit.
Read more »
Dr. Anthony Fauci says data from remdesivir coronavirus drug trial shows 'quite good news'CNBC's Meg Tirrell breaks down White House health advisor Dr. Anthony Fauci's comments on Gilead's possible coronavirus treatment.
Read more »
Dr. Fauci says remdesivir trial shows drug has promise as FDA plans to announce emergency use'What it has proven is a drug can block this virus,' Fauci said Wednesday while speaking to reporters at the White House.
Read more »
Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatmentGilead says preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of remdesivir improved, and more than half were discharged from the hospital within 2 weeks.
Read more »
Gilead reports 'positive data' on remdesivir coronavirus drug trial
Read more »